New lipid esters of nucleoside monophosphates use as immunosuppresive drugs

The present invention is directed to new nucleoside monophosphate derivatives of lipid ester residues of general formula (I) wherein R may be a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, R may be hydrogen, a straight-chain or branched, saturated or uns...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANS-GEORG OPTIZ, HARALD ZILCH, ALFRED MERTENS, DIETER HERRMANN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HANS-GEORG OPTIZ
HARALD ZILCH
ALFRED MERTENS
DIETER HERRMANN
description The present invention is directed to new nucleoside monophosphate derivatives of lipid ester residues of general formula (I) wherein R may be a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, R may be hydrogen, a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, X represents sulfur, a sulfinyl or sulfonyl group;and Nucl. represents 2',3'-Didesoxy-2',3'-difluorothymidine 2'-Desoxy-2'-aminoadenosine 2'-Desoxy-2'-azidoadenosine 2'-Desoxy-2'-azidocytidine 2'-Desoxy-5-fluorouridine 2-Fluoro-2'-desoxyadenosine their tautomers and their physiologically acceptable salts of inorganic and organic acids and/or bases, as well as to processes for their preparation, and to drugs containing said compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA954374B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA954374B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA954374B3</originalsourceid><addsrcrecordid>eNqFyrEKwjAUBdAuDqL-grwfcGpFHFUUQXBycimhvbWBJu-Rm-jvu7g7neXMq9sdH5m8-V7AjETRQWLpJih9Dwka1UaljS6DUghxFB9CicpilkD_hvSpvLisZoObiNXPRbW-nB-n6wamLWiuQ0Run4f9tql3zbH-G76CDjU9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New lipid esters of nucleoside monophosphates use as immunosuppresive drugs</title><source>esp@cenet</source><creator>HANS-GEORG OPTIZ ; HARALD ZILCH ; ALFRED MERTENS ; DIETER HERRMANN</creator><creatorcontrib>HANS-GEORG OPTIZ ; HARALD ZILCH ; ALFRED MERTENS ; DIETER HERRMANN</creatorcontrib><description>The present invention is directed to new nucleoside monophosphate derivatives of lipid ester residues of general formula (I) wherein R may be a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, R may be hydrogen, a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, X represents sulfur, a sulfinyl or sulfonyl group;and Nucl. represents 2',3'-Didesoxy-2',3'-difluorothymidine 2'-Desoxy-2'-aminoadenosine 2'-Desoxy-2'-azidoadenosine 2'-Desoxy-2'-azidocytidine 2'-Desoxy-5-fluorouridine 2-Fluoro-2'-desoxyadenosine their tautomers and their physiologically acceptable salts of inorganic and organic acids and/or bases, as well as to processes for their preparation, and to drugs containing said compounds.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19961129&amp;DB=EPODOC&amp;CC=ZA&amp;NR=954374B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19961129&amp;DB=EPODOC&amp;CC=ZA&amp;NR=954374B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANS-GEORG OPTIZ</creatorcontrib><creatorcontrib>HARALD ZILCH</creatorcontrib><creatorcontrib>ALFRED MERTENS</creatorcontrib><creatorcontrib>DIETER HERRMANN</creatorcontrib><title>New lipid esters of nucleoside monophosphates use as immunosuppresive drugs</title><description>The present invention is directed to new nucleoside monophosphate derivatives of lipid ester residues of general formula (I) wherein R may be a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, R may be hydrogen, a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, X represents sulfur, a sulfinyl or sulfonyl group;and Nucl. represents 2',3'-Didesoxy-2',3'-difluorothymidine 2'-Desoxy-2'-aminoadenosine 2'-Desoxy-2'-azidoadenosine 2'-Desoxy-2'-azidocytidine 2'-Desoxy-5-fluorouridine 2-Fluoro-2'-desoxyadenosine their tautomers and their physiologically acceptable salts of inorganic and organic acids and/or bases, as well as to processes for their preparation, and to drugs containing said compounds.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEKwjAUBdAuDqL-grwfcGpFHFUUQXBycimhvbWBJu-Rm-jvu7g7neXMq9sdH5m8-V7AjETRQWLpJih9Dwka1UaljS6DUghxFB9CicpilkD_hvSpvLisZoObiNXPRbW-nB-n6wamLWiuQ0Run4f9tql3zbH-G76CDjU9</recordid><startdate>19961129</startdate><enddate>19961129</enddate><creator>HANS-GEORG OPTIZ</creator><creator>HARALD ZILCH</creator><creator>ALFRED MERTENS</creator><creator>DIETER HERRMANN</creator><scope>EVB</scope></search><sort><creationdate>19961129</creationdate><title>New lipid esters of nucleoside monophosphates use as immunosuppresive drugs</title><author>HANS-GEORG OPTIZ ; HARALD ZILCH ; ALFRED MERTENS ; DIETER HERRMANN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA954374B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1996</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANS-GEORG OPTIZ</creatorcontrib><creatorcontrib>HARALD ZILCH</creatorcontrib><creatorcontrib>ALFRED MERTENS</creatorcontrib><creatorcontrib>DIETER HERRMANN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANS-GEORG OPTIZ</au><au>HARALD ZILCH</au><au>ALFRED MERTENS</au><au>DIETER HERRMANN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New lipid esters of nucleoside monophosphates use as immunosuppresive drugs</title><date>1996-11-29</date><risdate>1996</risdate><abstract>The present invention is directed to new nucleoside monophosphate derivatives of lipid ester residues of general formula (I) wherein R may be a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, R may be hydrogen, a straight-chain or branched, saturated or unsaturated alkyl chain having 1-20 carbon atoms, X represents sulfur, a sulfinyl or sulfonyl group;and Nucl. represents 2',3'-Didesoxy-2',3'-difluorothymidine 2'-Desoxy-2'-aminoadenosine 2'-Desoxy-2'-azidoadenosine 2'-Desoxy-2'-azidocytidine 2'-Desoxy-5-fluorouridine 2-Fluoro-2'-desoxyadenosine their tautomers and their physiologically acceptable salts of inorganic and organic acids and/or bases, as well as to processes for their preparation, and to drugs containing said compounds.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA954374B
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
title New lipid esters of nucleoside monophosphates use as immunosuppresive drugs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T04%3A28%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANS-GEORG%20OPTIZ&rft.date=1996-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA954374B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true